data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Artelo Biosciences

(NASDAQ:ARTL)

Intraday

$1.25

-0.08[-6.02%]

After-Hours

$1.25

0[0.00%]

Perks Buy Compare Brokers

$1.25

-0.08[-6.02%]

At close: Apr 26

$1.25

0[0.00%]

After Hours: 7:53PM EDT

Overview News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest News for Artelo Biosciences Stock (NASDAQ:ARTL)

Artelo Biosciences Stock (NASDAQ: ARTL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, April 23, 2024

Artelo Biosciences Reports Publication Peer-Reviewed Article Titled "The emerging role of fatty acid binding protein 7 (FABP7) in cancers,"
Benzinga Newsdesk - 3 days ago

Tuesday, April 02, 2024

HC Wainwright & Co. Maintains Buy on Artelo Biosciences, Maintains $5 Price Target
Benzinga Newsdesk - Apr 2, 2024, 11:42AM

Monday, March 25, 2024

Artelo Biosciences Earlier Reported Q4 EPS $(0.99) Misses $(0.56) Estimate
Happy Mohamed - Mar 25, 2024, 4:29PM
Recap: Artelo Biosciences Q4 Earnings
Benzinga Insights - Mar 25, 2024, 9:20AM
Artelo Biosciences FY23 EPS $(3.14) Vs $(3.56) YoY
Benzinga Newsdesk - Mar 25, 2024, 8:20AM

Wednesday, March 20, 2024

Artelo Biosciences Has Been Granted European Patent Number EP3723752 Titled "NEW SOLID FORMS OF CANNABIDIOL AND USES THEREOF (FOR VARIOUS MEDICAL TREATMENTS)"
Benzinga Newsdesk - Mar 20, 2024, 12:06PM

Wednesday, March 06, 2024

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Mar 6, 2024, 4:31PM

Tuesday, January 23, 2024

Artelo Biosciences Announces Publication Of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12's Effectiveness In Treating And Preventing Oxaliplatin-Induced Peripheral Neuropathy
Benzinga Newsdesk - Jan 23, 2024, 8:32AM

Monday, January 08, 2024

Artelo Biosciences Announces Selection Of Worldwide Clinical Trials As Clinical Research Organization To Support First-In-Human Study Of ART26.12
Benzinga Newsdesk - Jan 8, 2024, 8:47AM

Thursday, December 21, 2023

Artelo Biosciences Filed U.S. Patent Application #20230404939: Solid Forms Of Cannabidiol And Uses Thereof
Charles Gross - Dec 21, 2023, 7:22AM

Tuesday, December 05, 2023

Artelo Biosciences Presents New Preclinical Data On ART12.11 At The 4th Annual Med-Cannabis 2023 Conference In Germany
Benzinga Newsdesk - Dec 5, 2023, 8:36AM

Thursday, November 30, 2023

Artelo Biosciences To Present Important New Preclinical Data On ART12.11 At The 4th Annual Med-Cannabis 2023 Conference In Germany
Benzinga Newsdesk - Nov 30, 2023, 9:01AM

Tuesday, November 14, 2023

HC Wainwright & Co. Reiterates Buy on Artelo Biosciences, Maintains $5 Price Target
Benzinga Newsdesk - Nov 14, 2023, 6:46AM

Monday, November 13, 2023

Artelo Biosciences Q3 EPS $(0.83) Misses $(0.65) Estimate; $12.9 M In Cash And Investments
Benzinga Newsdesk - Nov 13, 2023, 8:29AM
Recap: Artelo Biosciences Q3 Earnings
Benzinga Insights - Nov 13, 2023, 8:25AM

Thursday, November 09, 2023

Artelo Biosciences Announces Publication Of New Peer-Reviewed Research Demonstrating Protective Properties Of ART27.13 Against Muscle Degeneration Caused By Certain Cancers
Benzinga Newsdesk - Nov 9, 2023, 9:23AM

Thursday, November 02, 2023

Artelo Biosciences To Present Preclinical Data Showcasing Research On ART26.12 And ART12.11 In Anxiety And Depression At Neuroscience 2023
Benzinga Newsdesk - Nov 2, 2023, 8:54AM

Wednesday, November 01, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Nov 1, 2023, 5:31PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Nov 1, 2023, 9:06AM

Monday, October 30, 2023

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Oct 30, 2023, 5:31PM

Friday, October 13, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Oct 13, 2023, 5:31PM

Thursday, September 07, 2023

Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Sep 7, 2023, 1:19PM
Why WestRock Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Sep 7, 2023, 8:10AM
Artelo Biosciences Has Completed A Pre-IND (Investigational New Drug) Meeting With The FDA Regarding The Development Plan For ART26.12; The Company Plans To File An IND Application For ART26.12 In Neuropathic Pain In 1H Of 2024
Benzinga Newsdesk - Sep 7, 2023, 8:06AM

Wednesday, September 06, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Sep 6, 2023, 5:31PM

Thursday, August 24, 2023

Cannabis Stock Gainers And Losers From August 24, 2023
Benzinga Insights - Aug 24, 2023, 5:30PM

Tuesday, August 15, 2023

Marijuana Stock Movers For August 15, 2023
Benzinga Insights - Aug 15, 2023, 5:30PM

Thursday, August 10, 2023

Artelo Q2 Net Loss Declines 33% YoY, Here Is What You Need To Know
Vuk Zdinjak - Aug 10, 2023, 11:16AM
Artelo Biosciences Q2 EPS $(0.56) Up From $(0.75) YoY
Benzinga Newsdesk - Aug 10, 2023, 8:11AM

Monday, July 24, 2023

Cannabis Stock Movers For July 24, 2023
Benzinga Insights - Jul 24, 2023, 5:30PM

Thursday, July 13, 2023

Five Studies Point To Effectiveness Of Artelo Biosciences' CBD Drug Candidate For Cancer Pain – FDA IND Application The Next Step
Johnny Rice - Jul 13, 2023, 8:46AM

Tuesday, June 27, 2023

Artelo Unvails New Data On ART26.12 Demonstrating Positive Effects In Multiple Models Of Neuropathic Pain
Vuk Zdinjak - Jun 27, 2023, 11:06AM
Artelo Biosciences Announces New Data On ART26.12 Demonstrating Effects In Multiple Models Of Neuropathic Pain At The 33rd Annual International Cannabinoid Research Society Symposium
Happy Mohamed - Jun 27, 2023, 8:41AM

Monday, June 26, 2023

Artelo Biosciences Presents Groundbreaking Research At Annual CBD Symposium In Canada
Joana Scopel - Jun 26, 2023, 9:03PM
Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties And Efficacy Of ART12.11 Compared To Cannabidiol At The 33rd Annual International Cannabinoid Research Society Symposium
Happy Mohamed - Jun 26, 2023, 8:43AM

Thursday, May 11, 2023

Artelo Biosciences: Q1 Earnings Insights
Benzinga Insights - May 11, 2023, 8:55AM
Artelo Biosciences Q1 EPS $(0.76) Beats $(0.93) Estimate
Benzinga Newsdesk - May 11, 2023, 8:20AM

Friday, April 28, 2023

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights - Apr 28, 2023, 1:49PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 28, 2023, 1:31PM

Wednesday, April 26, 2023

Artelo Enters Next Phase Of Evaluation Of Its Cannabinoid Receptor Targeting Drug For The Treatment Of Cancer-Related Anorexia And Weight Loss
Vuk Zdinjak - Apr 26, 2023, 8:59AM

Tuesday, April 25, 2023

Artelo Biosciences Initiates The Phase 2a Portion Of Its CAReS Trial EvaluatingART27.13 For The Treatment Of Cancer-Related Anorexia And Weight Loss
Happy Mohamed - Apr 25, 2023, 8:31AM

Monday, April 03, 2023

Ladenburg Thalmann Reiterates Buy on Artelo Biosciences, Maintains $60 Price Target
Benzinga Newsdesk - Apr 3, 2023, 7:22AM

Friday, March 31, 2023

Artelo Biosciences Reports FY22 Year-End Financial Results And Provides Business Update; EPS $(3.56) Vs $(1.81) YoY; As Of December 31, 2022, The Company Had ~$17.5M In Cash
Happy Mohamed - Mar 31, 2023, 8:26AM

Friday, February 03, 2023

HC Wainwright & Co. Reiterates Buy on Artelo Biosciences, Maintains $55 Price Target
Benzinga Newsdesk - Feb 3, 2023, 6:12AM

Thursday, February 02, 2023

Artelo Biosciences Completes Enrollment Of Phase 1b Stage Of iIs CAReS Clinical Trial Evaluating ART27.13 For Treatment Of Cancer-Related Anorexia And Weight Loss
Benzinga Newsdesk - Feb 2, 2023, 9:14AM

Tuesday, January 17, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jan 17, 2023, 4:31PM

Thursday, December 22, 2022

Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket
Lisa Levin - Dec 22, 2022, 6:17AM

Tuesday, November 08, 2022

Artelo Biosciences Q3 EPS $(0.82) Up From $(1.37) YoY
Benzinga Newsdesk - Nov 8, 2022, 8:12AM

Tuesday, August 23, 2022

Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket
Lisa Levin - Aug 23, 2022, 7:36AM

Thursday, August 18, 2022

This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Lisa Levin - Aug 18, 2022, 4:59AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved